Prosecution Insights
Last updated: April 19, 2026

VANDA PHARMACEUTICALS INC.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18629598 DEPOT ADMINISTRATION OF ILOPERIDONE HELM, CARALYNNE E 1615 Non-Final OA Apr 08, 2024
18527638 TREATMENT OF ACUTE ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATOR KUCKLA, ANNA GRACE 1626 Non-Final OA Dec 04, 2023
18249920 TREATMENT OF PUBLIC SPEAKING ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST WHITE, DAWANNA SHAR-DAY 1627 Non-Final OA Oct 18, 2023
18448868 METHOD OF TREATMENT WITH TRADIPITANT HANEY, AMANDA MARIE 1682 Final Rejection Aug 11, 2023
17981739 TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT PIHONAK, SARAH 1627 Final Rejection Nov 07, 2022
17906940 IDENTIFICATION AND USE OF COMPOUNDS IN THE TREATMENT OR PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 BOESEN, CHRISTIAN C 1684 Non-Final OA Sep 21, 2022

Managing VANDA PHARMACEUTICALS INC.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month